Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO), a developer of innovative medical technology, today announced that it has formed a subsidiary from which to conduct the business of its First Warning™ System designed to assist in the early detection of breast cancer.
Jim Holmes, Lifeline’s CEO stated, “Now that the First Warning Systems™ interpretative software patent has been filed, a new Lifeline Biotechnologies wholly owned subsidiary, First Warning Systems, Inc. has been created.